Research and new developments for psoriatic arthritis
An Arthritis Research UK-funded study has found that early aggressive drug treatment, compared with standard care, leads to 'significantly' better outcomes for people with psoriatic arthritis.
This study, which was published in The Lancet in October 2015, suggests that patients can greatly benefit from a targeted dose of the relevant medication early after their diagnosis. This should then be closely monitored and rapidly increased if the patient fails to show a response.
Researchers believe that the findings show this targeted approach significantly improves the symptoms affecting the joints and skin of newly diagnosed patients, with no unexpected side effects.
Scientists are working to find the exact causes of psoriatic arthritis. It's now possible to scan human genetic material to look for genes that increase the likelihood of psoriasis and psoriatic arthritis. This is likely to bring completely new developments in the next few years.
In addition, new MRI techniques are now telling us more about the sites of inflammation in the disease, which will lead to better targeted therapies.